New Delhi, Nov 26: The transfer of genetic information in the intact form to the progeny is the cornerstone of the perpetuation of life on…
Innovation hub launched to tackle antimicrobial resistance
New Delhi, Nov 22: The Department of Biotechnology’s Centre for Cellular and Molecular Platforms (C-CAMP), has launched a global collaborative platform to help reduce the…
India International Science Festival, 2021, launched
New Delhi, Nov 20: Dr M Ravichandran, Secretary, Ministry of Earth Sciences (MoES), launched the 7th edition of the India International Science Festival (IISF), from…
New biotechnology centre set up at Arunachal Pradesh
New Delhi, Nov 20: A new biotechnology centre has been set up in Kimin, a remote area of Arunachal Pradesh to help improve the socio-economic…
India stresses global engagement to achieve climate change goals
New Delhi, Nov 20: India has called for commitment from the global clean energy community for access to sustainable fuels, chemicals, and materials to reduce…
Dr. Rajesh S. Gokhale appointed as Secretary DBT
New Delhi, Oct. 27: Dr. Rajesh S. Gokhale, an esteemed scientist of the National Institute of Immunology (NII) New Delhi, has been appointed as the…
Facility to help MedTech startups
New Delhi: The Department of Biotechnology’s Centre for Cellular and Molecular Platforms (C-CAMP) has set up a national facility to specifically address the commercialization gaps…
DBT Institute to help Vietnamese company develop COVID vaccine
New Delhi, Sep 24: After helping several Indian companies in the development of vaccines for COVID-19 including clinical trials, the Department of Biotechnology (DBT)’s Translational…
New study to help develop salt-tolerant plants
New Delhi: Efforts to make use of mangrove plants to meet the increasing need for food production in the wake of a growing world population…
DCGI approves advanced trials for Biological E. Limited’s COVID- 19 vaccine
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in…